Literature DB >> 8454344

Neutrophil Fc receptor participation in phagocytosis of type III group B streptococci.

F J Noya1, C J Baker, M S Edwards.   

Abstract

Human peripheral blood neutrophils bear receptors for immunoglobulin G, FcRII, and FcRIII that differ structurally and functionally. We investigated the role of FcRII and FcRIII in the phagocytosis of group B streptococci (GBS) by measuring neutrophil uptake of radiolabeled type III GBS. The mean uptake of GBS opsonized with human serum containing complement and specific antibody was 76%, but when this serum was heated, the mean uptake was only 22%. A monoclonal antibody to FcRIII, Leu-11b, inhibited in a dose-dependent manner uptake of GBS opsonized with heated or intact serum to maxima of 40 and 30%, respectively. Conversely, a monoclonal antibody to FcRII, IV.3, inhibited by 77% the uptake of GBS opsonized with heated serum but had no effect when GBS was opsonized with intact serum. Leu-11b and IV.3 had an additive inhibitory effect with heated but not with intact serum. Neither monoclonal antibody inhibited the uptake of GBS opsonized with hypogammaglobulinemic serum. Therefore, FcRII is the primary mediator of the phagocytosis of GBS opsonized by antibody alone, whereas FcRIII plays a lesser role. Surprisingly, FcRII is not necessary for phagocytosis when complement is also present. FcRIII participates, to a limited extent, in phagocytosis of GBS opsonized with antibody whether or not complement is present. These findings suggest that the function of FcRII in triggering phagocytosis may be particularly important in host defense against type III GBS in the setting of complement deficiency of young infants.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8454344      PMCID: PMC281379          DOI: 10.1128/iai.61.4.1415-1420.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  Role of antibody and complement in opsonization of group B streptococci.

Authors:  A O Shigeoka; R T Hall; V G Hemming; C D Allred; H R Hill
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

2.  Opsonic specificity of human antibody to the type III polysaccharide of group B Streptococcus.

Authors:  M S Edwards; C J Baker; D L Kasper
Journal:  J Infect Dis       Date:  1979-12       Impact factor: 5.226

3.  Blockade of Fc receptor-mediated binding to U-937 cells by murine monoclonal antibodies directed against a variety of surface antigens.

Authors:  R J Kurlander
Journal:  J Immunol       Date:  1983-07       Impact factor: 5.422

4.  Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci.

Authors:  M S Edwards; D L Kasper; H J Jennings; C J Baker; A Nicholson-Weller
Journal:  J Immunol       Date:  1982-03       Impact factor: 5.422

5.  Participation of immunoglobulins and complement components in the intracellular killing of Staphylococcus aureus and Escherichia coli by human granulocytes.

Authors:  P C Leijh; M T van den Barselaar; M R Daha; R van Furth
Journal:  Infect Immun       Date:  1981-09       Impact factor: 3.441

6.  Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection.

Authors:  C J Baker; D L Kasper
Journal:  N Engl J Med       Date:  1976-04-01       Impact factor: 91.245

7.  Luminol-enhanced chemiluminescence for evaluation of type III group B streptococcal opsonins in human sera.

Authors:  D C Anderson; M S Edwards; C J Baker
Journal:  J Infect Dis       Date:  1980-03       Impact factor: 5.226

8.  Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis.

Authors:  C J Barnstable; W F Bodmer; G Brown; G Galfre; C Milstein; A F Williams; A Ziegler
Journal:  Cell       Date:  1978-05       Impact factor: 41.582

9.  Role of neutrophil receptors in opsonophagocytosis of coagulase-negative staphylococci.

Authors:  G E Schutze; M A Hall; C J Baker; M S Edwards
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

10.  The role of specific antibody in alternative complement pathway-mediated opsonophagocytosis of type III, group B Streptococcus.

Authors:  M S Edwards; A Nicholson-Weller; C J Baker; D L Kasper
Journal:  J Exp Med       Date:  1980-05-01       Impact factor: 14.307

View more
  7 in total

1.  Nonopsonic binding of type III Group B Streptococci to human neutrophils induces interleukin-8 release mediated by the p38 mitogen-activated protein kinase pathway.

Authors:  E A Albanyan; J G Vallejo; C W Smith; M S Edwards
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

2.  L-ficolin and capsular polysaccharide-specific IgG in cord serum contribute synergistically to opsonophagocytic killing of serotype III and V group B streptococci.

Authors:  Mioko Fujieda; Youko Aoyagi; Kousaku Matsubara; Yasuhito Takeuchi; Wakae Fujimaki; Misao Matsushita; John F Bohnsack; Shinji Takahashi
Journal:  Infect Immun       Date:  2012-03-26       Impact factor: 3.441

3.  Lectin site interaction with capsular polysaccharide mediates nonimmune phagocytosis of type III group B streptococci.

Authors:  E A Albanyan; M S Edwards
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

4.  Capsular polysaccharide regulates neutrophil complement receptor interactions with type III group B streptococci.

Authors:  M S Edwards; M R Wessels; C J Baker
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

5.  Human immunoglobulin G (IgG) Fc receptor IIA (CD32) polymorphism and IgG2-mediated bacterial phagocytosis by neutrophils.

Authors:  L A Sanders; R G Feldman; M M Voorhorst-Ogink; M de Haas; G T Rijkers; P J Capel; B J Zegers; J G van de Winkel
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

6.  Stress-induced differences in primary and secondary resistance against bacterial sepsis corresponds with diverse corticotropin releasing hormone receptor expression by pulmonary CD11c+ MHC II+ and CD11c- MHC II+ APCs.

Authors:  Xavier F Gonzales; Aniket Deshmukh; Mark Pulse; Khaisha Johnson; Harlan P Jones
Journal:  Brain Behav Immun       Date:  2007-12-31       Impact factor: 7.217

Review 7.  Group B streptococcus and early-onset sepsis in the era of maternal prophylaxis.

Authors:  Joyce M Koenig; William J Keenan
Journal:  Pediatr Clin North Am       Date:  2009-06       Impact factor: 3.278

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.